Novartis CEO: Medical Innovation, Tech Partnerships, and European Competitiveness
In Good Company with Nicolai Tangen
00:00
Navigating Innovation in European Pharma
This chapter examines Novartis's proactive partnership with tech companies and the challenges faced by the European pharmaceutical industry amidst growing concerns of commoditization and market size decline compared to the US and China. The discussion highlights the need for coordinated reforms within the EU to enhance competitiveness and adapt to the evolving landscape of global biopharmaceuticals. It also reflects on China's regulatory improvements and the implications of restricting clinical trial data exchange between the US and China on innovation and access to medicines.
Transcript
Play full episode
